Canton Strategic Holdings Inc (CNTN) vs Cue Biopharma, Inc. (CUE)
A side-by-side comparison of Canton Strategic Holdings Inc and Cue Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTN
Canton Strategic Holdings Inc
$2.34HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CUE
Cue Biopharma, Inc.
$24.22HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — CNTN vs CUE
growth of $100 · dividends reinvested · last 5yCNTN -99.8% (-71.8%/yr)CUE -92.2% (-39.9%/yr)CUE compounded faster over this window
Log scale — wide-divergence pair
CNTN CUE
CNTN vs CUE: by the numbers
- •CNTN is the larger company ($180M vs $176M market cap).
- •Both run net losses; CUE's is the smaller (-435.83% vs -6559.27% net margin).
Metrics side by side
Valuation
| Metric | CNTN | CUE |
|---|---|---|
| P/S ratio | 120.64 | 4.67 |
| P/B ratio | 0.40 | 76.17 |
Profitability
| Metric | CNTN | CUE |
|---|---|---|
| Gross margin | 0.00% | 99.69% |
| Operating margin | 0.00% | -96.56% |
| Net margin | -6559.27% | -435.83% |
| ROE | -21.57% | -7104.24% |
| ROIC | -9.57% | -1039.56% |
Growth (annualized)
| Metric | CNTN | CUE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 47.08% |
| Total return CAGR (5Y) | N/A | -42.42% |
Go deeper
Dig into the metrics
Canton Strategic ROECue Biopharma ROECanton Strategic operating marginCue Biopharma operating marginCanton Strategic revenue growthCue Biopharma revenue growthCanton Strategic free cash flowCue Biopharma free cash flow
Canton Strategic & Cue Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.